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Abstract
Objectives:  To  describe  the  trends  of  research  design  in  publications  from  high-impact  medical
journals.
Methods:  A  cross-sectional,  descriptive  study  was  conducted  by  searching  the  2011  electronic
publications  of  the  journals:  New  England  Journal  of  Medicine,  Journal  of  the  American  Medical
Association,  The  Lancet,  British  Medical  Journal,  and  Annals  of  Internal  Medicine.  Studies  were
classified  as  primary  and  secondary.  The  journal  impact  factor  was  taken  from  the  Journal
Citation  Report  website.  Descriptive  statistics  were  used  to  analyze  and  interpret  the  data.
Results: We  analyzed  1130  publications:  804 primary  and  326 secondary  studies,  which  rep-
resented 71.2%  and  28.8%  of the  total  publications,  respectively.  Among  the  primary  studies,
randomized clinical  trials  (30.4%)  were  the  most  prevalent,  followed  by  cohort  studies  (21.9%)
and case  reports  (9.0%).
Conclusions:  These  findings  can  have implications  in  Evidence-Based  Medicine  programs.  Liter-
ature review  should  focus  on  reviewing  secondary  articles  first,  then  experimental  studies  and
finally,  observational  studies.
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Introduction
In the area  of  continuous  medical  education,  in order  to
achieve  the gold  standard  in medical  attention,  growth  and
current  information,  frequent  review  of  medical  literature
is  necessary.  In modern  medicine,  healthcare  excellence  is
combined  with  scientific  rigor  in the practice  of  evidence-
based  medicine  (EBM).  This  new  paradigm  in medical
education  integrates  the use  of the best  clinical  evidence
http://dx.doi.org/10.1016/j.rmu.2015.04.002
1665-5796/© 2015 Published by Masson Doyma México S.A. on behalf of  Universidad Autónoma de Nuevo León. This is an open access article
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and  experience  in  the  diagnostic  and  therapeutic  decision-
making  process.  Proposed  in 1992,1 its  implementation
has  been  replacing  the authoritarian  management  and  the
purely  heuristic  in medicine.  Using  competences  such  as
search  strategies,  critical  reading  and the application  of  evi-
dence  to  the  context  of  the patient2,3 to create  and  base  an
intervention.  Some  of its objectives  are:  to  promote  criti-
cal  thinking,  to promote  continuous  learning,  to  reduce  the
impact  of  medical  error  and  improve  the patient’s  progno-
sis.  Nevertheless,  despite  having  acceptance  among  some
medical  circles;  critics  point out  the  difficulty  of integrating
EBM  into  clinical  practice.4--6 They  question  its  epistemo-
logical  value7,8 and  comment  regarding  the  resistance  of its
implementation  in some  health centers  and universities.9
Regarding  medical  education,  the integration  of  a
dynamic  learning  model  must  deliver  results  and  content.  An
adequate  curriculum  should  categorize  content  according  to
its  level  of  complexity  and  difficulty.  In the evidence-based
medicine  scenario,  the competences  must  prepare  doctors
to  evaluate  and  integrate  the  best  evidence  in order  to  gen-
erate  an  answer  to a clinical  problem.  But,  taking  this  into
consideration,  what  does  it take  to  answer  a  clinical  ques-
tion?  In the  process  of  critical  reading,  a  study  can  apply
to  clinical  context  if it  complies  with  internal  and  exter-
nal  validity.  Therefore,  the search  of  studies  with  a high
level  of  evidence  is  the  first  step.  This  represents  a fact
in  medical  journals  with  a  high  impact  factor.  First,  in  the
review-by-pairs  process,  reviewers  included  in  the editorial
committee  publish  in high  impact  journals.10 Concerning  the
researcher’s  participation,  they  recruit  a  higher  number  of
patients,  evaluate  major  results  and analyze  subgroups.11
With  the  selection  of  publications,  the ‘‘method’’  section
is  evaluated  on  the integrity  of the  statistical  analysis,12
while  in  ‘‘results’’,  the  inclusion  of  a confidence  interval13
and  clinical  significance  range  is  common.14 Despite  all  of
the  above,  research  design  may  offer  a replicable  example
of  information  with  high  clinical  value. Thus,  the  objective
of  the  present  study  is  to  examine  the  publication  tenden-
cies  in the  different  research  designs  in high-impact  medical
journals.
Materials and  methods
A  transversal  descriptive  study  was  conducted.  We  eval-
uated  issues  of  the following  journals  published  during
2011:  The  New England  Journal  of Medicine,  Journal
of  the  American  Medical  Association,  Annals  of  Internal
Medicine,  The  Lancet  and  BMJ.  The  impact  factor  was
obtained  from  the Journals Citation  Report.15 These  pub-
lications  were  then  classified  as  primary  (originals)  and
secondary  (revisions)  studies  according  to  their  focus.  The
main  studies  section was  sub-divided  according  to the
type  of  study  and  experimental  (randomized  clinical  tri-
als)  and  observational  designs  (prevalence,  control  case
and cohort).  The  secondary  studies  section  included:  nar-
rative  review  and systematic  review,  with  and  without
meta-analysis,  excluding  genomic  studies  of  this  cate-
gory.
Descriptive  statistics  were  utilized  for  better  data  mana-
gement  and  interpretation.
Results
Out  of the 1130  publications  analyzed  in 2011,  the jour-
nals  published  an average  of  3  main  studies  and  1  secondary
study  per  issue  (results  shown  in Table  1).  337 randomized
clinical  trials  (30.4%)  were  published  in the main  studies  cat-
egory.  On the other  hand,  observational  studies  243 (21.9%),
included  102  cohorts  (9.02%),  59  case  reports  (5.2%)  and
52  (4.6).  Regarding  the  secondary  studies,  226  publications
were  classified  as  narrative  reviews  (20%),  67  as  systemic
reviews  (5.9%)  and  33  as  systemic  reviews  with  meta-analysis
(2.9%).
The New  England  Journal  of  Medicine  published  241 arti-
cles,  divided  as follows:  0  (0%)  meta-analysis,  1 (0.5%)
systematic  review,  33  (15.55%)  narrative  reviews,  110
(51.4%)  clinical  essays,  17 (7.9%)  cohorts,  6 (2.8%)  control
cases,  5  (2.3%)  prevalence  and  42  (19.6%) case  reports.
The  Lancet  published  337 articles,  divided  as  follows:
6  (1.8%)  meta-analysis,  3 (0.9%)  systematic  reviews,  120
(35.6%) narrative  reviews,  110 (29.7%)  randomized  clinical
trials,  46 (13.6%)  cohorts,  4 (1.2%)  control  cases,  5 (1.2%)
prevalence  and  53  (15.7%)  case  reports.
The  Journal  of  the  American  Medical  Association,  for  its
part,  published  202  studies,  divided  as  follows:  18  (8.9%)
meta-analysis,  2 (1%)  systematic  reviews,  14  (6.9%)  narrative
reviews,  42  (20.8%)  randomized  clinical  trials,  81  (40.1%)
cohorts,  32  (15.8%)  control  cases,  10  (5%)  prevalence  and  3
(1.5%)  case  reports.
BMJ  included  270  publications,  divided  as  follows:  1
(0.4%)  meta-analysis,  43  (15.9%)  systematic  reviews,  53
(19.6%)  narrative  reviews,  72  (26.7%)  randomized  clinical
trials,  69  (25.6%)  cohorts,  15  (5.6%)  control  cases,  17  (6.3%)
prevalence  and  0  (0%)  case  reports.
Last  but  not  least,  Annals  of  Internal  Medicine  published
107  studies,  divided  as  follows:  8  (7.5%)  meta-analysis,  18
(16.8%)  systematic  reviews,  6 (5.6%)  narrative  reviews,  20
(18.7%)  randomized  clinical  trials,  34 (31.8%)  cohorts,  2
(1.9%)  control  cases,  15  (14%)  prevalence  and  4  (3.7%)  case
reports.
Regarding  original  studies,  NEJM  published  180 (84.1%),
The  Lancet  208 (61.7%),  JAMA  168  (83.2%),  BMJ  173 (64.1%)
and  Annals  of  Internal  Medicine  75  (70.1%).  The  tendencies
for secondary  studies  were  NEJM  34  (15.9%),  The  Lancet
129  (38.3%),  JAMA  34  (16.8%),  BMJ  97  (35.9%)  and  Annals
of  Internal  Medicine  32  (39.9%).
Discussion
In  our  frequency  distribution  analysis,  publication  distribu-
tion  was  linked  to  evidence  levels.  Randomized  clinical  trials
were  the  most represented  studies,  followed  by  cohorts.
Our  results  suggest  that  medical  journals  with  a high-impact
factor  publish  studies  with  a high  evidence  level (Fig.  1).
A relevant  finding  significantly  documented  in The  New
England  Journal  of Medicine  and  The  Lancet  was  the  high
frequency  with  which  case  reports  were  published,  repre-
senting  up to  15% of the  total  of  their  publications.  Another
major  finding  is the  tendencies  the  journals  have  according
to  their  geographic  location.  European  journals  (The  Lancet
and  BMJ)  published  secondary  studies  to  a  greater  extent
(Fig.  2).  These  findings  raise  a question:  What  implications
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Figure  1 Distribution  of  observational  and  experimental  stud-
ies.
can  this  have?  In order  to  answer  this  question  correctly,  the
limitations  and  advantages  of each  design  were  evaluated.
Experimental  studies  represent  a high  degree  of  evi-
dence  since  they  allow  a direct  determination  of the
causal  connection  of  two  phenomena.  Another  significant
point  is  its  ability  to reduce  the  amount  of  systematic
errors.16 With  randomization,  an equilibrium  between  the
characteristics  of  the compared  groups  is  established.
Blinding,  concealment  and  intention-to-treat  analysis allow
the  reduction  of skewing  in any  type of  randomized  clinical
trial.  Unfortunately,  one  of  the biggest  disadvantages  of
RCT  is  in the  context  of clinical  practice.  Paradoxically,
internal  factors  such as  the strict  inclusion  criteria,  eval-
uation  of efficiency  and  short-term  follow-up17 limit  the
study’s  ability  to  establish  a  general  conclusion.  The  fact
that  significant  results  are obtained  does  not necessarily
mean  that  they  can  be  applied  in a ‘‘real  life’’  scenario.  In
other  words,  the results  at that  moment  only apply  to  the
population  being  studied.  Also  external  factors  of the study
like  high  costs,  ethical  considerations18 and  low financing
in the case  of  rare  diseases  are also  an important  issue.
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Figure  2 Distribution  of  original  and secondary  studies.
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Consequently,  the  difficulty  in  clinical  trials  relies  more
importantly  on  external  validation.
Observational  studies  represent  the lowest  level in the
evidence  hierarchy.  They  are useful  in clinical  scenarios  like
in  evaluating  disparity  and  load  and determining  risk  factors
which  contribute  to  the development  of a disease.19 In medi-
cal  history,  cohorts  play an  important  role  in documenting
associations,  like  in the Framingham  study,  or  the conclusive
data  of  the  effectiveness  of  insulin  analogs  for  the  treatment
of  patients  with  type 1  or  2 diabetes.20 Additionally,  cohort
studies  help  determine  safety  profiles  of  medications.  For
example,  the  SCOUT  study  assessed  the effectiveness  of
sibutramine  in 10,744  patients  with  obesity  and high  cardio-
vascular  risk  for  a  period  of  6 years.  Compared  to  placebos,
the  sibutramine  group  showed  a  noticeable  increase  in mor-
tality  rates  and  cardiovascular  events  despite  the  significant
weight  loss.21 This  influenced  its recall  by  the  FDA  in 2009.
In  contrast  with  experimental  studies,  studies  with-
out  intervention  represent  a clearer,  uncontrolled  and
unadjusted  model  of the  disease.  Nevertheless,  internal
validation  is  an important  issue.  The  highest  difficulty  in
observational  studies  lies  in interpretation,  since  there  are
some  factors  like bias  in selection,  confusion  factors or  recall
bias  and  thus  the  results  may  lead  to  different  conclusions.
According  to  the information  obtained,  it  is  possible
to  conclude  that  there  are  different  problems  in research
within  primary  studies.  European  and  American  magazines
have  different  criteria  concerning  their  publication’s  guide-
lines;  in  other  words,  there  is  no  standard  in the  level of
evidence  regarding  article  revision.  Perhaps  a major  implica-
tion  in  relation  to  the impact  factor  lies more  in  the context
of  transnational  medicine.  That is  to  say,  The  New England
Journal  of  Medicine  published  mostly  randomized  clinical
trials,  studies  frequently  cited  and  with  a higher  impact  in
medical  practice.  Hence,  a  dichotomy  is formed  between
the  management  of  concepts:  validity  versus  generalization.
Observational  studies  are not as  valid; however  they  include
concepts  which  are  more  applicable  in  populations.  On the
contrary,  experimental  studies  have  a great  epistemological
value,  but  only  represent  the  set  of  the  population  being
studied.
Secondary  studies  represent  the highest  level  of  evi-
dence.  They  offer  a  summary  of  the  investigation  question.
In  the  context  of  evidence-based  medicine,  both  validity  and
generalization  are  important.  The  findings  in these  studies
have  a  greater  approximation  to  the Bradford--Hill  criteria;
nevertheless,  the limitation  in secondary  studies  lies  in  the
presence  of  publication  bias.
One  of  the  strengths  of  this  study  was  the analysis  of  a
representative  sample  of the publications  in different  jour-
nals  in  the  yearly  period.  A  similar  trend  was  reported  in
a  study  conducted  in 2003,  but  with  different  objectives22
and  a  much  smaller  sample.  A  limitation  of the  study  was
the  classification  of evidence  according  to  the  study  design,
without  evaluating  the existence  of  discrepancies  in  the
methodology,  like the  presence  of  bias  or  the  weight  of
confusion  factors.
In  conclusion,  the tendency  of  publications  or  journals
with  a  high  impact  factor  is  oriented  to  a greater  extent  to
the  publication  of primary  and  observational  studies;  how-
ever,  European  journals  such as  The  Lancet  and BMJ  publish
a  good  amount  of  secondary  studies.  Future  studies  are
necessary  to  determine  not only  the validity,  but  also  the
impact  of an  article.  The  amount  of quotations  correlated
with  the  publication  of  studies  with  a high  level  of  evidence.
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